Advertisement

Topics

Avid Radiopharmaceuticals Company Profile

04:46 EST 15th December 2018 | BioPortfolio

Founded in 2004, Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. Two of Avid's radiopharmaceuticals are already in clinical trials, and Avid intends to make these products available to pharmaceutical companies that are seeking to develop new drugs for treatment of Alzheimer's disease. By providing a readily measured biomarker for this disease, Avid's products can facilitate testing of therapies aimed at amyloid plaques. Avid's first commercial product for the Alzheimer's diagnostic market is ready for development and will be used for positron emission tomography (PET).

Location

3701 Market Street, 3rd Floor
Philadelphia
Pennsylvania
19104
United States of America

Contact

Phone: 215-966-6208
Email: skovronsky@avidrp.com


News Articles [65 Associated News Articles listed on BioPortfolio]

Eli Lilly's New PET Scan Offers Another Tool for Studying Alzheimer's

Eli Lilly and Company and its wholly-owned subsidiary Avid Radiopharmaceuticals, announced the successful Phase III trial of a Positron Emission Tomography (PET) imaging agent, flortaucipr F 18, in id...

Avid Bioservices Appoints CFO

Daniel Hart will be responsible for overseeing and managing all of Avid’s accounting and finance responsibilities

Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET Imaging Agent

INDIANAPOLIS, Sept. 5, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced that a Phase 3 study of flortauci...

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index. The post 5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices o...

Avid expansion to triple process development capacity, says CEO

Avid continues its transition to a fully-fledged CDMO by transforming its process development capabilities with new lab space.

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Outlook to 2023: High Prevalence of Cancer & Heart Diseases – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Diagnostic Radiopharmaceuticals & Contrast Media Market – Radiopharmaceuticals Segmented by Type of Imaging, Application, Contrast Media...

Novartis buys radiopharmaceuticals company Endocyte for $2.1bn

Novartis AG agreed to acquire public radiopharmaceuticals firm Endocyte Inc. (targeted cancer therapies and companion imaging agents) for $24 in cash per share (a 55% premium), for an equity value of ...

Eight Things To Know From Novartis' Third Quarter Call

The company's $2.1bn acquisition of Endocyte and expansion into radiopharmaceuticals dominated some of the call, but with the launches of...   

PubMed Articles [97 Associated PubMed Articles listed on BioPortfolio]

Adverse Reactions to Radiopharmaceuticals: A Survey Based on Clinical Cases Using Criteria of Systematic Review.

Adverse reactions to radiopharmaceuticals are still not reported worldwide. However, the type of reaction may be severe and cause death. A review of the literature was performed using some criteria of...

Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma.

The indication for surgery is controversial in patients with advanced ovarian cancer and fluorodeoxyglucose (FDG)-avid mediastinal lymph nodes. Herein we report our experience in thoracoscopic resecti...

Stability study of 18Ffludeoxyglucose and 18Ffluorocholine in different medical devices for intravenous administration.

[18F]-radiopharmaceuticals registered as ready-to-use drugs are prepared in multi-dose flasks. When the change of packaging must be made extemporaneously for the preparation of patient unit doses in a...

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.

Post I-131 ablation single-photon emission computed tomography (SPECT)/CT can show radioactive iodine (RAI)-avid cervical metastatic lymph nodes (mLN) in differentiated thyroid cancer. This study aime...

Validation of the Semi-Automatic Quantification of F-Fluoride PET/CT Whole-body Skeletal Tumor Burden.

To validate a semi-automatic quantification of the skeletal tumor burden on F-Fluoride PET/CT by using manual quantification as a reference. We quantified 51 F-Fluoride PET/CT exams performed on fema...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Antiarrhythmics Versus Implantable Defibrillators (AVID)

To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated...

Combination Targeted Radiotherapy in Neuroendocrine Tumors

RESEARCH PLAN / BACKGROUND AND SIGNIFICANCE: Tumors originating from the neuroendocrine system, although relatively rare, may be life threatening. In cases where the disease has metastasi...

18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.

18F ion is a positron emitting bone radiopharmaceuticals. The skeletal uptake of 18F relies on the exchange of hydroxyl ions in the hydroxyapatit crystal which is an indicator of bone meta...

Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy

Patients with primary head and neck squamous cell carcinoma (HNSCC) planned for treatment with radiotherapy with or without chemotherapy in curative setting will be treated with an adaptiv...

PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors

PET has an established role in the initial staging of patients with newly diagnosed lung and gastrointestinal tumors.PET avidity is described with both maximum and mean standardized uptake...

Companies [36 Associated Companies listed on BioPortfolio]

Avid Radiopharmaceuticals

Founded in 2004, Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. Two of A...

Avid Radiopharmaceuticals, Inc.

Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of maj...

Avid Bioservices, Inc.

Avid Bioservices provides a comprehensive range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid manufactures cGMP commercial product, as well as clinical s...

Coquí RadioPharmaceuticals Corp.

Coquí RadioPharmaceuticals Corp. is a medical isotope company, dedicated to the production of Molybdenum-99, which is used in 20 million procedures each year in the U.S. The Pu...

CORAR

The Council on Radionuclides and Radiopharmaceuticals (CORAR) is an association comprised of companies in the United States and Canada who manufacture and distribute radiopharmace...

More Information about "Avid Radiopharmaceuticals" on BioPortfolio

We have published hundreds of Avid Radiopharmaceuticals news stories on BioPortfolio along with dozens of Avid Radiopharmaceuticals Clinical Trials and PubMed Articles about Avid Radiopharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avid Radiopharmaceuticals Companies in our database. You can also find out about relevant Avid Radiopharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record